Peptides have become shorthand for sophisticated skincare. And somewhere along the way, a number started appearing beside them: 500 Daltons. The suggestion is tempting. If a molecule is smaller than 500 Daltons, it must be able to slip through skin and get to work. Right?
Not quite. Molecular size matters, but skin is more selective than a simple size chart suggests. Understanding the difference helps you read peptide claims with a clearer eye.
What is the 500 Dalton rule?
A Dalton is a unit of molecular mass. In 2000, dermatologists Jan Bos and Marcus Meinardi proposed a useful rule of thumb: compounds that pass through intact skin by ordinary passive diffusion are generally small, often below roughly 500 Daltons. Their argument drew on patterns among topical drugs and contact allergens, rather than a clinical trial comparing cosmetic peptides.
The original paper in Experimental Dermatology remains influential. But it is a guideline about a barrier, not a guarantee of delivery or results. A molecule weighing 450 Daltons is not automatically effective; one weighing 550 Daltons is not automatically useless in every formulation.
Why skin doesn't work like a kitchen sieve
Picture the outermost skin layer, the stratum corneum, as tightly packed bricks surrounded by a carefully arranged lipid mortar. For many ingredients, crossing that mortar is the difficult part. A small molecule may still struggle if it is highly water-loving, strongly charged or poorly suited to moving through skin lipids.
Formulation matters, too: the surrounding ingredients can influence how a substance dissolves, partitions into skin and moves through it. A review of skin permeation describes molecular mass, charge, oil–water affinity and the delivery vehicle as interacting factors. Think of molecular weight as one line on a résumé, not the entire application.
What do peptide studies actually show?
Some peptides face a genuine delivery challenge
Many peptides are water-loving and contain groups that can carry a charge, which makes passive movement through the lipid-rich outer barrier difficult. A 2011 review of KTTKS, a five-amino-acid peptide used in cosmetic research, examined how its chemistry could limit delivery. A 2022 review likewise emphasizes that getting anti-wrinkle peptides to their intended sites is an important unresolved formulation challenge.
These are reviews of ingredients and delivery science—not proof that all peptide creams fail, or that any particular one succeeds.
Finding an ingredient in skin is not the same as proving a wrinkle benefit
A particularly interesting 2022 study using ex vivo human skin tracked a palmitoylated peptide, Pal-GHK, after topical application. Researchers detected it within the stratum corneum; the measured signal declined with depth and approached baseline near the boundary with the living epidermis. That is valuable evidence about where an ingredient went. It is not a clinical demonstration that the tested formulation reduced wrinkles in living people.
It also does not tell us how a different peptide, in a different cream, will behave. The details are the science.
How researchers test skin penetration
Rather than relying on a molecular-weight label, researchers can examine delivery directly. In laboratory diffusion experiments, human skin separates a formulation from a receiving compartment. Other techniques, including confocal Raman spectroscopy, can measure substances at different depths in living skin.
A 2020 study compared laboratory diffusion testing with measurements in human volunteers for niacinamide delivered from several experimental vehicles. It found that the choice of vehicle changed delivery substantially. Niacinamide is not a peptide, so this is an illustration of why formulation-specific testing matters, not evidence for a peptide product.
Even good penetration data answer only one question. To support a visible-firmness or wrinkle claim, researchers would still need appropriate human outcome studies of the relevant formula.
What this means when choosing a moisturizer
At Domi Skin, our Peptide Barrier Moisturizer lists copper lysinate/prolinate among its ingredients. The molecular-weight discussion is useful context, but the studies linked here did not test the penetration, clinical performance or long-term effects of Domi's finished moisturizer. We would not treat a sub-500-Dalton description as proof that its copper complex reaches a particular skin layer.
A moisturizer can still be worth using for simpler reasons: how comfortably it wears, whether it helps skin feel less dry, and whether you enjoy using it consistently. Those are reasonable everyday priorities without turning every ingredient into a dramatic promise.
If you are comparing peptide products, look for clear ingredient information, realistic language and evidence relevant to the finished formula whenever a brand makes specific performance claims. The U.S. FDA's cosmetics testing guidance also makes an important distinction: cosmetic safety responsibilities do not mean the agency has approved a product's claimed results.
A few quick questions
Does under 500 Daltons mean an ingredient reaches the dermis?
No. Being small enough to be a plausible candidate for passive penetration does not establish how deeply it travels, how much arrives, or whether it produces a visible effect.
Can a larger peptide ever be useful in skincare?
Potentially. Some formulas aim for effects at or near the surface, while researchers are also exploring delivery strategies for harder-to-transport molecules. What matters is evidence for the particular ingredient, formulation and intended benefit.
Should I choose a cream based on molecular weight alone?
We wouldn't. Treat it as one technical detail alongside the full formula, skin comfort, product quality and trustworthy testing. The Domi Effect is about building a routine that makes sense—not collecting the most impressive-sounding numbers.